In recent months, I’ve noticed a troubling trend with AI coding assistants. After two years of steady improvements, over the ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

Beyond all the AI hype and headlines, here are five trends you should watch for in 2026 and beyond as AI sweeps into seafood.

Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

Python stays far ahead; C strengthens at #2, Java edges past C++, C# is 2025’s winner; Delphi returns, R holds #10.

TIOBE Index for January 2026: Top 10 Most Popular Programming Languages Your email has been sent January’s TIOBE Index begins the year with familiar names still setting the pace, but the underlying ...

The World Anti-Doping Agency (WADA) wishes to remind stakeholders that the 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program are now in force as of today (1 January ...

The ReproSci project retrospectively analyzed the reproducibility of 1006 claims from 400 papers published between 1959 and 2011 in the field of Drosophila immunity. This project attempts to provide a ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Eric's career includes extensive work in ...

The three main differences between index funds and mutual funds are management style, investment objective and cost. Index funds tend to be the clear winner over the long term. Many, or all, of the ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Pete Rathburn is a copy editor and fact ...

ASCO GI 2026 GLP-1 Drugs Tied to Lower CRC Risk and Better Outcomes New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes ...